The U.S. Food and Drug Administration is currently reviewing whether to limit testosterone replacement therapy (TRT) to certain narrowly defined conditions. See: Will the FDA Tighten the Use of Testosterone Replacement Therapy? Knowing how the FDA works on these things, it’s a good bet that restriction of TRT will be the order of the day.
Ironic – or hypocritical – it is that estrogen-related hormones are handed out to women like candy. But men face high scrutiny when asking for TRT. Let’s call it the War on Men. But that’s neither here nor there, since there’s nothing we can do about it.
If you need TRT, whether due to age or some other reason, count on facing extra scrutiny from your doctor. Although the FDA ruling may only affect drug companies’ ability to advertize testosterone, and not your doctor’s ability to prescribe it, you can bet that doctors will be extra wary about it with the possibility of the FDA or state boards breathing down their necks.
I would say that this gives extra impetus to the use of aromatase inhibitors, which I discussed both here and in my book. Aromatase inhibitors, such as anastrozole, can increase testosterone levels by 50 to 100%, and doctors will be more likely to prescribe them.
Another aromatase inhibitor is diindolylmethane (DIM), an OTC supplement. However, I’m not aware of any studies that showed an increase in T with DIM. (If any reader is aware of one, I’d appreciate leaving a link in comments.)
Resveratrol is also an aromatase inhibitor, and in rats, it doubled sperm counts and T levels.